Rennova Health, Inc.
RNVA
RNVA was delisted on the 24th of October, 2017.
5 hedge funds and large institutions have $100K invested in Rennova Health, Inc. in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
150% more funds holding
Funds holding: 2 → 5 (+3)
6% less capital invested
Capital invested by funds: $106K → $100K (-$6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$27.2K |
| 2 |
Renaissance Technologies
New York
|
+$20.4K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$6.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
RNVA Hedge Fund Activity: Q3 2014 in Review
5 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q3 2014, worth a combined $100K — down 5.7% from $106K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RNVA positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $27.2K. The largest seller was Tower Research Capital (TRC), cutting an estimated $2K.
- 5 institutional investors held Rennova Health, Inc. (RNVA) as of Q3 2014, up from 2 in Q2 2014.
- Funds reported $100K of Rennova Health, Inc. stock for Q3 2014, down 5.7% quarter-over-quarter.
- 3 funds opened new Rennova Health, Inc. positions in Q3 2014 and 0 closed out, a net change of +3 holders.
- The largest Rennova Health, Inc. buyer in Q3 2014 was Citadel Advisors, an estimated $27.2K added.
- The largest Rennova Health, Inc. seller in Q3 2014 was Tower Research Capital (TRC), an estimated $2K sold.
Based on aggregated 13F filings for Q3 2014.